The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Contact phoneSparrow Clinical Research Institute | 517.364.5760
Principal investigatorDr. Nam Cho, DO
Trial CategoryHeart & Vascular
Trial SubCategoryAtrial Fibrillation